Evidence map›Paper›PMID 30312324›Full record

ArticlePloS one2018

SNPSelect: A scalable and flexible targeted sequence-based genotyping solution.

René C J Hogers, Marjo de Ruiter, Koen H J Huvenaars, Hein van der Poel, Antoine Janssen, Michiel J T van Eijk, Nathalie J van Orsouw

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

René C J HogersKeygene NV, Wageningen, Gelderland, The Netherlands.
Marjo de RuiterKeygene NV, Wageningen, Gelderland, The Netherlands.
Koen H J HuvenaarsKeygene NV, Wageningen, Gelderland, The Netherlands.
Hein van der PoelKeygene NV, Wageningen, Gelderland, The Netherlands.
Antoine JanssenKeygene NV, Wageningen, Gelderland, The Netherlands.
Michiel J T van EijkKeygene NV, Wageningen, Gelderland, The Netherlands.
Nathalie J van OrsouwKeygene NV, Wageningen, Gelderland, The Netherlands.ORCID 0000-0001-5552-0204

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In plant breeding the use of molecular markers has resulted in tremendous improvement of the speed with which new crop varieties are introduced into the market. Single Nucleotide Polymorphism (SNP) genotyping is routinely used for association studies, Linkage Disequilibrium (LD) and Quantitative Trait Locus (QTL) mapping studies, marker-assisted backcrosses and validation of large numbers of novel SNPs. Here we present the KeyGene SNPSelect technology, a scalable and flexible multiplexed, targeted sequence-based, genotyping solution. The multiplex composition of SNPSelect assays can be easily changed between experiments by adding or removing loci, demonstrating their content flexibility. To demonstrate this versatility, we first designed a 1,056-plex maize assay and genotyped a total of 374 samples originating from an F2 and a Recombinant Inbred Line (RIL) population and a maize germplasm collection. Next, subsets of the most informative SNP loci were assembled in 384-plex and 768-plex assays for further genotyping. Indeed, selection of the most informative SNPs allows cost-efficient yet highly informative genotyping in a custom-made fashion, with average call rates between 88.1% (1,056-plex assay) and 99.4% (384-plex assay), and average reproducibility rates between duplicate samples ranging from 98.2% (1056-plex assay) to 99.9% (384-plex assay). The SNPSelect workflow can be completed from a DNA sample to a genotype dataset in less than three days. We propose SNPSelect as an attractive and competitive genotyping solution to meet the targeted genotyping needs in fields such as plant breeding.

Indexed as

Polymorphism, Single NucleotideChromosome MappingGene FrequencyGenetic CodeGenotypeGenotyping TechniquesPlant BreedingReproducibility of ResultsSequence Analysis, DNATime FactorsWorkflowZea mays

Identifiers

PMID30312324
PMCPMC6185863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.